X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/855081/fsd-pharma-provides-another-update-on-celly-nus-anticipated-launch-of-unbuzzdtm
https://www.accesswire.com/853779/fsd-pharma-expands-investigative-pipeline-to-include-potential-weight-loss-and-liver-health-formulations-and-products
https://www.accesswire.com/853010/fsd-pharma-provides-update-on-its-investment-in-celly-nutrition-corp-a-company-launching-a-product-that-can-assist-in-expediting-alcohol-metabolism-and-faster-recovery-from-alcohol-consumption
https://www.accesswire.com/847963/fsd-pharma-announces-filing-of-year-end-2023-results
https://www.accesswire.com/847236/fsd-pharma-signs-the-agreement-with-ingenu-cro-to-conduct-a-clinical-study-to-assess-the-safety-and-pharmacokinetics-of-multiple-ascending-doses-of-lucid-21-302-lucid-ms-in-healthy-adults
https://www.accesswire.com/841153/fsd-pharma-submits-a-phase-1b-clinical-trial-application-for-ethics-committee-for-its-proprietary-beverage-unbuzzdtm
https://www.accesswire.com/839246/fsd-pharma-presents-positive-results-on-first-in-human-phase-1-study-of-lucid-21-302-lucid-ms-at-americas-committee-for-treatment-and-research-in-multiple-sclerosis-actrims-2024-forum
Market Place
Share 
